Ivermectin is not a proven cancer treatment, and no major medical organization recommends it for that purpose
Ivermectin is an antiparasitic medication—it kills parasitic worms and certain insects. It has been used safely for decades to treat conditions like river blindness and head lice. In 2015, two of its developers won a Nobel Prize for its antiparasitic work. But antiparasitic activity is not the same as anticancer activity, and the two do not transfer between diseases.
Some laboratory studies have found that ivermectin can slow the growth of cancer cells in a petri dish or in mice. Laboratory findings do not mean a drug works in human bodies. Thousands of substances kill cancer cells in a lab. Almost none of them become cancer treatments. The step from "works in cells" to "works in patients" requires human trials, and ivermectin has not completed them for cancer.
The National Cancer Institute, the American Cancer Society, the FDA, and the European Medicines Agency have all stated that ivermectin is not an established cancer treatment. No major cancer center—Memorial Sloan Kettering, Mayo Clinic, MD Anderson, or others—lists it as a treatment option for any cancer type.
Key Takeaways
- Ivermectin kills parasites and has shown activity against cancer cells in laboratory settings, but laboratory results do not predict how a drug will work in human patients.
- No completed human trials have shown that ivermectin treats any form of cancer, and no regulatory agency has approved it for cancer treatment.
- Taking ivermectin instead of proven cancer treatments delays care that has been shown to work and reduces your chances of survival.
- If you are considering ivermectin for cancer, discuss it with your oncologist before starting, because it can interact with other medications and may affect your treatment plan.
Why laboratory results do not mean a drug will work in patients
When researchers test a drug in cells or animals, they are answering a narrow question: does this substance have any effect on cancer cells at all? The answer is often yes. But human bodies are vastly more complex than a petri dish. A drug must survive stomach acid, cross the blood-brain barrier if needed, reach cancer cells in the right concentration, and do this without poisoning healthy tissue.
Ivermectin at the doses used to treat parasites is not the same as ivermectin at the doses tested in lab cancer studies. Higher doses might be needed to affect cancer, but higher doses also increase the risk of side effects. No one knows whether the dose that might theoretically help cancer would be safe in a human being.
This is why the FDA requires human trials before approving any drug for a new use. A drug that works in mice fails in humans roughly 90 percent of the time. The 10 percent that succeed have been tested in hundreds or thousands of people, with their safety and effectiveness carefully measured.
What human trials on ivermectin and cancer have actually shown
A small number of human studies have looked at ivermectin in cancer patients, but none have been large enough or rigorous enough to show that it works. Most have been observational studies—meaning researchers watched what happened to patients who took it, rather than comparing them to patients who did not. Observational studies cannot prove cause and effect.
One 2020 study in colorectal cancer patients found no benefit from ivermectin. Another looked at a combination of drugs including ivermectin in breast cancer and found no improvement in survival. These are not the kinds of results that lead to approval or recommendation.
For ivermectin to become a recognized cancer treatment, it would need to complete Phase 1, Phase 2, and Phase 3 trials—a process that typically takes five to ten years and costs millions of dollars. No pharmaceutical company or research institution has invested in this process for ivermectin and cancer, because the early signals have not been strong enough to justify the cost.
The real risk of using unproven treatments instead of proven ones
Cancer is time-sensitive. The longer you wait to start a treatment that works, the more time the cancer has to grow and spread. If you spend weeks or months taking ivermectin while your cancer progresses, you may reach a point where standard treatments are no longer effective.
Proven cancer treatments—surgery, chemotherapy, radiation, immunotherapy, and targeted drugs—work because they have been tested in thousands of patients and their benefits have been measured against their risks. Your oncologist can tell you the actual odds that a treatment will help you, based on your specific cancer type and stage. Ivermectin comes with no such data.
There is also a financial cost. If you pay out of pocket for ivermectin while delaying covered treatments, you lose money and time. If you take ivermectin alongside your prescribed treatment, it may interact with your other medications in ways your doctor does not expect, potentially reducing the effectiveness of your actual cancer care.
Why people seek alternatives to standard cancer treatment
Cancer treatment is difficult. Chemotherapy and radiation have real side effects. Surgery is invasive. Immunotherapy can cause autoimmune reactions. The idea of a gentler, simpler option is understandably appealing. Ivermectin is cheap, widely available, and has a good safety record for parasites—which makes it seem like a reasonable choice.
But a good safety record for one disease does not mean safety for another. And a low price does not mean effectiveness. The appeal of ivermectin is emotional, not medical. It feels like an option because it exists and is accessible, not because evidence supports its use.
If you are struggling with the side effects of your current treatment, or if you have lost confidence in your oncologist, those are real problems worth addressing. Talk to your doctor about adjusting your treatment plan, getting a second opinion, or exploring clinical trials for newer approaches. These are evidence-based paths forward. Ivermectin is not.
What to do if you are considering ivermectin for cancer
If you have read about ivermectin online or heard about it from someone else, bring that information to your next oncology appointment. Do not start taking it on your own. Tell your doctor what you have read and why it appeals to you. A good oncologist will explain why the evidence does not support its use and will address your underlying concerns—whether those are about side effects, cost, or feeling like you are doing enough to fight your cancer.
If you want to explore newer or less common treatments, ask your oncologist about clinical trials. Clinical trials are research studies testing new approaches in human patients. They are free or low-cost, they are monitored for safety, and they give you access to treatments that are not yet widely available. Your doctor can help you search ClinicalTrials.gov or connect you with trials that match your cancer type and stage.
If you have lost trust in your current oncologist, get a second opinion from another cancer center. A second opinion is standard practice and does not offend most doctors. It can confirm your current treatment plan or reveal options you had not considered.
Frequently Asked Questions
Has ivermectin ever been approved by the FDA for cancer?
No. The FDA has approved ivermectin only for parasitic infections. It has never approved ivermectin for any cancer type, and no application for cancer approval has been submitted to the agency.
If ivermectin kills cancer cells in a lab, why can't doctors use it?
Many substances kill cancer cells in a petri dish but fail in human bodies. The jump from lab to patient requires human trials to prove safety and effectiveness. Ivermectin has not completed those trials for cancer, so there is no evidence it works in real patients.
Is it safe to take ivermectin while undergoing cancer treatment?
Ivermectin can interact with chemotherapy drugs, immunotherapy, and other medications. Do not take it without telling your oncologist. Even if ivermectin itself is safe at parasite-treatment doses, combining it with cancer drugs could reduce the effectiveness of your actual treatment or cause unexpected side effects.
What should I do if my cancer is not responding to standard treatment?
Talk to your oncologist about clinical trials, which test newer approaches in human patients. You can also get a second opinion from another cancer center. These are evidence-based options. Switching to an unproven treatment usually makes outcomes worse, not better.
Where can I find information about cancer treatments that are actually being studied?
ClinicalTrials.gov lists thousands of active cancer trials. Your oncologist can also recommend trials that match your diagnosis. The National Cancer Institute website has information about standard treatments for each cancer type, updated as new evidence emerges.